Circannual variation in the expression of beta 2-adrenoceptors on human peripheral mononuclear leukocytes (MNLs) by Haen, Ekkehard et al.
Kl in Wochenschr  (1988) 66:579-582 
Klinische 
Wochen- 
schrift 
© Springer-Verlag 1988 
Cireannual Variation in the Expression of fl2-Adrenoceptors 
on Human Peripheral Mononuclear Leukocytes (MNLs) 
E. Haen, I. Langenmayer, A. Pangerl, B. Liebl, and J. Remien 
Walther-Straub- Inst i tut  fiir Pharmakologie  und Toxikologie, Mi inchen 
Summary. Peripheral mononuclear leukocytes 
(MNLs) are widely used as a tissue model in stu- 
dies of fl-adrenoceptor disturbances in hyperten- 
sion and asthmatic diseases. The flz-adrenoceptor 
density (Bm,x), however, depends not only on the 
gender of the person under study and on the time 
of day the blood specimens are obtained. Evidence 
is now reported for a circannual variation in the 
expression of flz-adrenoceptor sites on peripheral 
MNLs. In male volunteers the 24-h mean was 
found to be highest in the men studied in April/ 
May (1135+_10 sites/cell) and decreased to 
891 +_ 16 sites/cell in August and to 712 + 90 sites/ 
cell in December (if_+ SE, P < 0.01 April/May com- 
pared to December). Concomitantly the circadian 
amplitude increased from 17.3%_+6.4% of 24-h 
mean in April/May to 28.2% _+ 1.4% of 24-h mean 
in August and to 34.2% +4.2% of 24-h mean in 
December (ff +_ SE, P < 0.05, April/May compared 
to December). The circadian acrophase remained 
constant (190°+30 ° equivalent to 12 h 40 rain+ 
2 h 00 rain, 2 +_ SE). 
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Mononuclear leukocytes (MNLs) are widely used 
as a tissue model in studies of #-adrenoceptor di-
sturbances in hypertensive [2, 6, 7] and asthmatic 
diseases [4, 12]. We recently reported a circadian 
variation in the expression offl2-adrenoceptors on 
Abbreviations: MNLs  = Peripheral mononuc lear  leucocytes; 
Bmax = f12-Adrenoceptor density; ~ z 5 ICYP = ~ z 5 Iodo-cyanopin-  
dolol; PEF=Peak  expiratory flow; SE=Standard  error; AN-  
OVA = Analysis of  variance; M = Circadian mesor;  A = Circa- 
dian ampl i tude;  ¢ = Circadian acrophase 
MNLs in humans [10]. Here we report evidence 
of a circannual variation in the expression of these 
receptors on MNLs. 
Materials and Methods 
Venous blood was drawn from the antecubital vein 
of 10 male volunteers, 19-34 years old, every 4 h. 
Immediately thereafter MNLs were harvested in 
each of the 68 specimens by density centrifugation 
using Ficoll-Hypaque [8]. Cells were incubated for 
120 min at 37°C with 10-12 concentrations of 
125ICYP in the range of 1.8-600 pmol (total bin- 
ding 7). Nonsaturable binding of the radioligand 
was determined in parallel incubations with 
10-6 mol/1 unlabelled (-)-t imolol  (unspecific bin- 
dung U). Specific binding (B) was calculated as 
the difference between total and unspecific binding 
(B= T -U) .  The data were iteratively fitted to a 
model of two independent classes of binding sites 
(a saturable high-affinity and a nonsaturable ow- 
affinity binding site) using a computer programm 
named MULTI  [9, 15]. The total number of high- 
affinity binding sites (Bmax) and their equilibrium 
dissociation constant (Ka) were obtained from the 
curve fit as parameters of the #2-adrenoceptor on 
MNLs [1]. 
Eight apparently healthy subjects were studied 
in April/May (n =4), August (n= 1), and Decem- 
ber (n = 3). In August two additional subjects were 
studied, who complained of mild nocturnal 
asthma. The 24-h mean of their peak expiratory 
flow (PEF), however, was within the normal range 
(597+33 t/min and 498_+29 l/rain, 2___SE) with a 
nocturnal dip of 30% of the 24-h mean at 0600 h 
and of 26% of the 24-h mean at 0200 h, respecti- 
vely. None of the subjects took any medication. 
The circadian variations were statistically vali- 
dated by cosinor analysis [3] and by an analysis 
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Fig. I. Circadian variation in the expression of fl2-adrenoceptor sites on mononuclear leukocytes in each of the 10 male subjects 
studied at different times during the year (April/May: numbers 1, 2, 3; August: numbers4, 5, 6; December: numbers 7, 8, 9, 
10). Subject no. 2 was restudied as no. 8 in December 
of variance (ANOVA); annual differences were te- 
sted using Student's t-test. P<0.05 was regarded 
as significant. The cosinor analysis also yielded the 
circadian mesor, the circadian amplitude, and the 
circadian acrophase as parameters of a circadian 
variation [5]: The circadian mesor (M) is defined 
as the midline of a cosine function with a period 
of 24 h fitted to the seven time-specified Bmax va- 
lues of each individual circadian variation; with 
equidistant data as in this study the mesor is equi- 
valent to the 24-h mean. The circadian amplitude 
(A) is defined as the maximal deviation of the fitted 
cosine function from its midline. The circadian ac- 
rophase (~)is defined as the time lag of the ma- 
ximum of the fitted cosine function :in reference 
to local midnight. 
Results 
A circadian variation in the expression of fl2-adre- 
noceptors on peripheral MNLs was detected in all 
individuals with maximal values around noon and 
minimal values around midnight (Fig. 1). The 
equilibrium dissociation constant for the high-affi- 
nity binding site showed neither a significant circa- 
dian nor a significant circannual variation. The 
arithmetic mean of the 68 determinations was 
4.5_+0.5 pmol/1 (~+_ SE). 
When the circadian variation parameters for 
the flz-adrenoceptor density of all healthy subjects 
were compared to those of the men complaining 
of nocturnal asthma no differences could be found 
(Table 1). Neither was there any difference, when 
Table 1. Parameters for the circadian variation in the expression 
of fl2-adrenoceptor sites on human mononuclear leukocytes as 
determined in male subjects (2_+ SE) 
Subjects n 24-h mean Circadian 
amplitude 
(sites/cell) (% of 24-h mean) 
2+_SE ~ iSE  
All apparently 8 892-I-98 25.8+_8.5 
healthy men 
Mild nocturnal 2 893 + 27 29.0 ± 2.0 
asthma in August 
Apparently healthy 1 890 28.5 
man in August 
the two men complaining of nocturnal asthma, 
who were both studied in August, were compared 
to the apparently healthy man studied in the same 
month (Table 1). 
If the same data were analyzed according to 
the months the experiments were performed, a cir- 
cannual variation became apparent in the expres- 
sion of fl2-adrenoceptors on MNLs. The 24-h 
mean was highest in the men studied in April/May 
(1135 4-10 sites/cell) and decreased to 891 4-_ 16 si- 
tes/cell in August and to 712-t-90 sites/cell in De- 
cember (~+SE, P<0.01 April/May compared to 
December, Fig. 2). Concomitantly the circadian 
amplitude increased from 17.3%_+6.4% of 24-h 
mean in April/May to 28.2% 4-1.4% of 24-h mean 
in August and to 34.2% +4.2% of 24-h mean in 
December (~_+ SE, P < 0.05, April/May compared 
to December, Fig. 2). The circadian acrophase re- 
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Fig. 2. 24-h means (upper panel) and amplitudes (lower panel) 
of the circadian variation in the expression of/~2-adrenoceptor 
sites on human mononnclear leukocytes as determined in male 
subjects at different times during the year (ff--+SE). (% 24 h 
g: data expressed as a percentage of the 24 h mean) 
mained constant (190°_+30 ° equivalent o 12h 
40 min + 2 h 00 min, if_+_ SE). 
Discussion 
Disturbances in the expression and function of 
adrenoceptors have been discussed as pathophy- 
siological mechanisms in hypertension [2, 6, 7] and 
bronchial asthma [4, 12, 13]. Usually peripheral 
MNLs are used as tissue models in in vivo studies 
in humans. In our own investigations there is no 
evidence so far that a pathological alteration of 
the expression of/~2-adrenoceptors due to mild 
nocturnal asthma may be detected by studying 
MNLs of those subjects. If there should be such 
an alteration, it will be definitely less pronounced 
than physiologically occurring variations in the 
number of /q2-adrenoceptor sites expressed on 
MNLs. 
We recently demonstrated the influence of the 
time of day and of the subjects' gender on the 
expression of fl2-adrenoceptors on MNLs [4, 10]. 
Additional studies of apparently healthy men and 
individuals complaining of mild nocturnal asthma 
now provide evidence that also the time of year 
influences the pz-adrenoceptor density. As pointed 
out elsewhere, the circadian variation in the expres- 
sion of/~2-adrenoceptors n peripheral MNLs is 
correlated to the circadian variation of plasma 
adrenaline and cortisol concentrations resulting in 
an endogenous down- and up-regulation, respecti- 
vely [4]. We assume, therefore, that circannual va- 
riations in circulating catecholamine and glucocor- 
ticoid concentrations trigger the circannual varia- 
tion in the expression of/?z-adrenoceptor sites on 
MNLs. Data that are in agreement with such an 
assumption have been reported by Reinberg et al. 
[11] and Touitou et al. [14] for serum cortisol with 
a circannual acrophase in March and June, respec- 
tively. Data on a circannual variation f plasma 
catecholamine concentrations are still lacking. 
The evidence reported in this paper is a rather 
casual finding observed uring the evaluation of 
experiments designed to study circadian variations. 
To firmly establish the suggested circannual varia- 
tion it must be demonstrated intraindividually in
a sufficient number of subjects. Such studies are 
now in progress in our laboratory, and the results 
will be reported in about 2 years. 
Even now, however, we believe the evidence 
for a circannual variation in the expression of/~2- 
adrenoceptors on MNLs is strong enough that this 
factor should be taken into account in clinical stu- 
dies on ~z-adrenoceptors, together with the circa- 
dian variation and the differences between males 
and females already reported earlier [4, 10]. 
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